Zhang L - Search Results

1

Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule.

Wang M, Sun S, Wu T, Zhang L, Song H, Hao W, Zheng P, Xing L, Ji G. Wang M, et al. Among authors: zhang l. Evid Based Complement Alternat Med. 2013;2013:584634. doi: 10.1155/2013/584634. Epub 2013 May 16. Evid Based Complement Alternat Med. 2013. PMID: 23762146 Free PMC article.

2

Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals.

LU YL, HE YQ, WANG M, ZHANG L, YANG L, WANG ZT, JI G. LU YL, et al. Among authors: zhang l. Acta Pharmacol Sin. 2010 Dec;31(12):1635-42. doi: 10.1038/aps.2010.172. Acta Pharmacol Sin. 2010. PMID: 21127497 Free PMC article.

3

Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.

Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G. Xing LJ, et al. Among authors: zhang l. Eur J Pharmacol. 2011 Oct 15;668(3):467-71. doi: 10.1016/j.ejphar.2011.07.036. Epub 2011 Aug 4. Eur J Pharmacol. 2011. PMID: 21839075

4

[The joint pathway of metabolism and inflammation in nonalcoholic fatty liver disease].

Zhang L, Song HY, Ji G. Zhang L, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 May;19(5):395-7. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 21972445 Review. Chinese. No abstract available.

5

[Multi-mathematical modelings for compatibility optimization of Jiangzhi granules].

Yang M, Zhang L, Ge Y, Lu Y, Ji G. Yang M, et al. Among authors: zhang l. Zhongguo Zhong Yao Za Zhi. 2011 Dec;36(24):3439-43. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22368852 Chinese.

6

Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity.

Song HY, Mao ZM, Yang LL, Liu T, Li DF, Zhang L, Ge YL, Zheng PY, Liu P, Zhang XQ, Ji G. Song HY, et al. Among authors: zhang l, zhang xq. J Tradit Chin Med. 2011 Dec;31(4):327-33. doi: 10.1016/s0254-6272(12)60013-2. J Tradit Chin Med. 2011. PMID: 22462240

7

[Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats].

Liu T, Yang LL, Zhang L, Song HY, Li DF, Ji G. Liu T, et al. Among authors: zhang l. Zhong Xi Yi Jie He Xue Bao. 2012 Oct;10(10):1120-6. doi: 10.3736/jcim20121008. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 23073195 Chinese.

8

Danshensu inhibits acetaldehyde-induced proliferation and activation of hepatic stellate cell-T6.

Zhang L, Wu T, Chen JM, Yang LL, Song HY, Ji G. Zhang L, et al. Zhong Xi Yi Jie He Xue Bao. 2012 Oct;10(10):1155-61. doi: 10.3736/jcim20121013. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 23073200

9

Update on berberine in nonalcoholic Fatty liver disease.

Liu Y, Zhang L, Song H, Ji G. Liu Y, et al. Among authors: zhang l. Evid Based Complement Alternat Med. 2013;2013:308134. doi: 10.1155/2013/308134. Epub 2013 Jun 17. Evid Based Complement Alternat Med. 2013. PMID: 23843872 Free PMC article.

10

Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis.

Song HY, Zhang L, Pan JL, Yang LL, Ji G. Song HY, et al. Among authors: zhang l. J Integr Med. 2013 Jul;11(4):262-8. doi: 10.3736/jintegrmed2013034. J Integr Med. 2013. PMID: 23867244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,052 results

Search Page

Filters